North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

The North America Androgenetic Alopecia Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).

The US market dominated the North America Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,143.2 Million by 2030. The Canada market is experiencing a CAGR of 9.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.3% during (2023 - 2030).



One of the primary drivers of adoption in the androgenetic alopecia market is the growing awareness and acceptance of hair loss as a common condition. As public understanding of androgenetic alopecia expands, more individuals seek information and solutions to address their concerns. This increased awareness has led to a shift in societal attitudes, with a greater acceptance of seeking medical or cosmetic interventions for hair loss. A decreasing stigma is associated with seeking cosmetic enhancements for both men and women. As societal norms change, individuals are more open to exploring various interventions to address their hair loss concerns, contributing to the overall adoption of treatments within the market.

Media and social media platforms are crucial in shaping beauty standards and influencing individual choices. Celebrity endorsements and testimonials regarding hair restoration treatments have become common, impacting the adoption rates within the market. High-profile figures openly discussing their experiences with hair loss treatments contribute to the normalization of seeking such interventions. Individuals from diverse locations can access information about different treatment options, connect with specialists, and choose interventions that suit their preferences and needs.

As per the International Trade Administration (ITA), in the first half of 2022, the Canadian cosmetics industry was the fastest-growing industry in the country. In 2022, Canada’s personal care and beauty sector earned around $11 billion in revenue. Advancements in technology, such as laser therapy, platelet-rich plasma (PRP) treatments, and robotic hair transplantation, are gaining popularity in Canada. Celebrity endorsements, media representation, and the influence of social media contribute to shaping beauty standards and aesthetic preferences in Canada. Also, ITA estimates by 2024, cosmetic industry revenue is anticipated to increase by 1.45% yearly to USD 1.8 billion. Hence, the factors mentioned above will drive the regional market growth.

Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Cipla Limited
• Merck & Co., Inc.
• GlaxoSmithKline PLC (GSK)
• Sun Pharmaceuticals Industries Ltd.
• Dr.Reddy’s Laboratories Ltd.
• Aurobindo Pharma Limited
• Pfizer, Inc.
• Lutronic Co., Ltd.
• Viatris Inc.
• Eli Lilly and Company

Market Report Segmentation

By Treatment

• Pharmaceuticals
• Devices

By Gender

• Male
• Female

By Sales Channel

• Prescriptions
• OTC

By End-use

• Dermatology Clinics
• Homecare Settings

By Country

• US
• Canada
• Mexico
• Rest of North America